About the Editors

Editor-in-Chief

Sang-Hyun Oh, PhD

University of Minnesota, Twin Cities
Minneapolis, Minnesota, USA

Prof. Oh leads a multi-disciplinary research group recognized for developing nanophotonic devices and associated manufacturing technologies such as template stripping and atomic-layer lithography. These techniques have contributed toward applications in nanoplasmonic biosensing, nanopore sensors, surface-enhanced spectroscopies, and microfluidics. Recently, his focus is on developing bioassays for the detection of prion and misfolded proteins implicated in neurodegenerative diseases, reflecting his commitment to real-world disease diagnostics. A graduate from KAIST, Korea (BS, Physics) and Stanford University (PhD, Applied Physics), Prof. Oh has been recognized with faculty awards from DARPA, ONR, NSF, ACS, and 3M. He is a Fellow of Optica.

Managing Editor

Ronghua Guo, PhD

Ronghua obtained her PhD degree in Geology from Nanjing University in 2021. During her PhD, she focused on the sedimentary provenance analysis with different detrital heavy minerals from modern river sands in the South Tibetan Plateau. She joined Springer Nature as an Editorial Submission Advisor in October 2021 and now serves as a Managing Editor for 5 titles in the npj Series. She is now based in the Springer Nature Nanjing office.

Associate Editor

Laura Fabris, PhD

Politecnico di Torino
Torino, Italy

Dr. Laura Fabris leads a multidisciplinary research group focusing on the development of novel methods for the synthesis and functionalization of plasmonic nanoparticles with the purpose of employing them in surface enhanced spectroscopies and nanoscale light-driven chemistry. One of the main areas of interest is the use of surface enhanced Raman spectroscopy for the implementation of low-cost, robust sensing approaches addressing important needs in biology and medicine. In particular, the Fabris lab is interested in developing liquid biopsy methods for prostate cancer biomarker detection and in leveraging spectroscopy for the study of viral evolution. Dr. Fabris earned B.S./M.S. and Ph.D. from the University of Padova (Italy) and was then a postdoc at the University of California Santa Barbara. She is an ERC Consolidator grant awardee.

Nam-Joon Cho, PhD

Nanyang Technological University
Singapore, Singapore

MRS-Singapore Chair Professor in the School of Materials Science and Engineering at Nanyang Technological University (NTU)
Director (Flagship Programmes)
Project Leader and Principal Investigator at the Stanford University SyneRx Antiviral Drug Discovery Center (AViDD)

Professor Nam-Joon Cho is a leading scholar of material science and infectious disease medicine.
He pioneered new fields in sustainability and healthcare: from antiviral peptide technology to develop broad-spectrum drugs responding to COVID-19, to transformation of plant pollen to replace environmentally harmful plastics.
Dr. Cho initiated a new paradigm for sustainability called “Cross Economy” which designs to create new industrial opportunities through material innovation including using the wastes. He works closely with healthcare companies and other industrial partners in these translational projects, including serving as Project Lead at Stanford University’s Antiviral Drug Discovery Centre for Pathogens of Pandemic Concern, where he spearheads collaborative research funded by the US National Institutes of Health. A pioneer in developing a new economic model for economic prosperity in hybrid worlds, he has received international honours from organisations such as the American Liver Foundation and Ministry of Science and ICT in South Korea. He is a member of the National Academy of Engineering of Korea.
His research efforts have resulted in over 280 scientific papers in top journals such as Nature Materials, Nature Medicine, Nature Communications, Nature Protocols, Nature Human Behaviour, Science Translational Medicine, and Science Advances. He currently received the funding from MOE, NRF of Singapore as well as NIH (US) to S23,000,000. The technology from his research group has been licensed and spun out to biotech companies with over $20,000,000 in investment funding.
Dr. Cho is also a passionate educator and mentor who has played leadership roles in the NTU Renaissance Engineering Programme, developed youth science education programs together with the United Nations and World Economic Forum, created international undergraduate research programs and joint graduate degree programs with leading university partners, and had group alumni become tenure-track faculty members and entrepreneurs worldwide. In addition, he currently serves as President of the Korean Scientist and Engineers Association in Singapore, is a member of the National Academy of Engineering of Korea. Earlier in his career, he was awarded the Nanyang Associate Professorship and Singapore National Research Foundation Fellowship.

He is a graduate of Stanford University and the University of California, Berkeley.

Hirotsugu Ogi, PhD

Osaka University
Suita, Osaka, Japan

bio/gas sensors, condensed-matter physics, and protein-aggregation sciences with originally developed acoustic methods, including picosecond ultrasonic spectroscopy, wireless QCM, and electromagnetic acoustic resonance.

Cullen Buie, PhD

Massachusetts Institute of Technology
Cambridge, MA, USA

Professor Buie leverages microfluidics and microscale transport phenomena for applications ranging from materials science to biotechnology. The Buie Lab explores both linear and no-linear electrokinetic phenomena for characterization and phenotyping of microbes. Recent work incorporates electric fields in microscale systems to deliver nucleic acids and proteins to microbes and human cells for applications in gene editing and synthetic biology.

Advisory Editor

Kate de Mattos Shipley, PhD

Kate joined the Biotechnology Team at Nature Communications in September 2021. After completing her PhD at the University of Bristol in 2011, Kate spent 10 years as a post-doctoral researcher working on natural products from fungi, uncovering the genetic basis of their biosynthesis and most recently genome-mining for new antibiotics. She handles manuscripts on biosensors and molecular biology methods. She is based in the London office.

Editorial Board Members

John Rogers, PhD, Northwestern University, Evanston, IL, USA
David Klenerman, PhD, University of Cambridge, Cambridge, UK
Teri Odom, PhD, Northwestern University, Evanston, IL, USA

Interested in joining the journal team?

If you are interested in joining the journal as an Editorial Board Member or Associate Editor, please complete this Google form. Associate Editors are part of the editorial team that handle manuscripts, while Editorial Board Members are regular reviewers and are consulted for ad hoc advice. We will contact you if your expertise meets the needs of the journal.

Nature Portfolio journals are committed to promoting practices that support diversity, equity and inclusion in science communication and publishing, and we strongly encourage gender, race, ethnic, geographic, career stage and other diversity in our journal teams. Our in-house staff will use your information only for the purposes of identifying new editorial team or board members. Please contact the journal by email if you would like to remove your information from these records.

Please note that we are not able to respond to all applicants.